Document is current
Any future updates will be listed below
-
Authors
Sachpekidis, Christos http://orcid.org/0000-0001-8739-8741
Merz, Maximilian
Raab, Marc-Steffen
Bertsch, Uta
Weru, Vivienn
Kopp-Schneider, Annette
Jauch, Anna
Goldschmidt, Hartmut
Dimitrakopoulou-Strauss, Antonia
-
Funding
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
- License Information
-
More Information
Article History
Received: 13 July 2021
Accepted: 23 September 2021
First Online: 9 October 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional (S-076/2010) and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: The given consent included also the consent for publication of anonymized data.
: Hartmut Goldschmidt<i>:</i> Grants and/or provision of Investigational Medicinal Product: Amgen, BMS, Celgene, Chugai, Dietmar-Hopp-Foundation, Janssen, John Hopkins University, Sanofi. Research Support (Institutions): Amgen, BMS, Celgene, Chugai, Janssen, Incyte, Molecular Partners, Merck Sharp and Dohme (MSD), Sanofi, Mundipharma, Takeda, Novartis. Advisory Boards (Institutions): Adaptive Biotechnology, Amgen, BMS, Celgene, Janssen, Sanofi, Takeda. Honoraria (Speakers Bureaus): Amgen, ArtTempi, BMS, Celgene, Chugai, GlaxoSmithKline (GSK), Janssen, Novartis, Omnia Med Deutschland, Sanofi. All other authors declare no conflicts of interest.
